Sheaff Brock Investment Advisors LLC Has $6.54 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Sheaff Brock Investment Advisors LLC lifted its holdings in CME Group Inc. (NASDAQ:CME) by 1.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,616 shares of the financial services provider’s stock after acquiring an additional 376 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in CME Group were worth $6,535,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Y.D. More Investments Ltd bought a new position in shares of CME Group in the second quarter valued at $36,000. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares during the period. McClarren Financial Advisors Inc. boosted its stake in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares during the last quarter. Asset Dedication LLC grew its holdings in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the period. Finally, New Covenant Trust Company N.A. purchased a new stake in CME Group in the 1st quarter worth about $82,000. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares in the company, valued at $5,587,935.64. This represents a 1.57 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the sale, the director now owns 10,589 shares in the company, valued at approximately $2,403,279.44. The trade was a 8.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 over the last three months. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Performance

CME stock opened at $223.42 on Friday. The company has a market cap of $80.45 billion, a P/E ratio of 23.49, a price-to-earnings-growth ratio of 5.26 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36. The stock’s fifty day moving average price is $222.44 and its 200-day moving average price is $210.17.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the company earned $2.25 earnings per share. On average, equities analysts forecast that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.06%. CME Group’s payout ratio is currently 48.37%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on CME shares. JPMorgan Chase & Co. increased their price target on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Piper Sandler lifted their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Keefe, Bruyette & Woods increased their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a research note on Thursday, October 24th. Finally, Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and an average target price of $224.47.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.